Pfizer, the drug manufacturing giant has issued a statement denying reports of fresh agreement between it and Kano state government over compensation with regards to the 1996 Trovan clinical study case.
Though the company said it continues to discuss with Kano state government, Pfizer said today“Contrary to a recent media report, however, there is no new agreement between Pfizer and Kano State concerning any additional compensation to be paid, and there has been no arbitration between the parties”.
Today’s statement said :“Pfizer continues to discuss with the Kano State government the progress of the independent Healthcare/Meningitis Trust Fund, which is responsible for providing compensation to persons who can prove they were participants in the 1996 Trovan clinical study. The Trust 
Fund has already paid compensation to a number of persons who demonstrated through DNA testing that they were study participants. Pfizer and Kano State continue to operate under the terms of the settlement agreement between them that was signed in 2009, under which persons qualified as study participants receive compensation from the Trust Fund. Contrary to a recent media report, however, there is no new agreement between Pfizer and Kano State concerning any additional compensation to be paid, and there has been no arbitration between the parties. It should be noted that there were only 200 participants in the clinical trial, but the Trust Fund received claims from over 500 applicants. Pfizer is hopeful that the Trust Fund will complete its work soon.”
